The pilot study will be similar to what will occur at the UK hospitals (which is on hold due to COVID-19) so I doubt these hospital currently have the resources to manage these pilot given what has occurred in Europe due to COVID-19, and the UK hospital haven't been given no-cost exclusivity license for all their private hospitals for another 6 months and a non-exclusive, no-cost license for an additional six 6 month after the initial 6 months pilot completion and RAP has formed an UK team recently.......
